Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial

Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0, reflecting a new version tag rather than content changes.
    Difference
    0.1%
    Check dated 2026-03-22T08:51:13.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. This change does not affect the study information or user workflows.
    Difference
    0.1%
    Check dated 2026-03-07T18:05:37.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No substantive changes to the study details or page layout are visible.
    Difference
    0.1%
    Check dated 2026-02-14T05:42:33.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-07T05:22:36.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Plain language trial summaries are now available on novctrd.com and 2026 update entries have been added; these changes are informational and do not affect core trial details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-31T02:56:29.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Additions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-23T23:59:13.000Z thumbnail image

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.